RecruitingNot Applicable

Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Spain42 participantsStarted 2022-03-28

Plain-language summary

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months). The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meet the Budapest criteria for the clinical diagnosis of CRPS type I. * Age between 18 and 65. * Period between 0 and 6 months after the onset of the clinical picture. * Have signed the informed consent of their own free will. Exclusion Criteria: * Have a diagnosis of CRPS type II. * Present type I CRPS in more than one limb. * Patients who have suffered a recurrence of CRPS type I. * Pregnancy or plans for it during the study. * Previous sympathectomy in the affected limb.

What they're measuring

Pain ( VAS)

Timeframe: Up to 6 month

Quick Dash Test

Timeframe: Up to 6 month

Trial details

NCT IDNCT05052736

SponsorUniversity of Las Palmas de Gran Canaria

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-27

Contact for this trial

Aníbal Báez-Suárez, PhD

+34 652077692 anibal.baez@ulpgc.es